DK136492D0 - A PHARMACEUTICAL FORMULATION - Google Patents

A PHARMACEUTICAL FORMULATION

Info

Publication number
DK136492D0
DK136492D0 DK136492A DK136492A DK136492D0 DK 136492 D0 DK136492 D0 DK 136492D0 DK 136492 A DK136492 A DK 136492A DK 136492 A DK136492 A DK 136492A DK 136492 D0 DK136492 D0 DK 136492D0
Authority
DK
Denmark
Prior art keywords
pharmaceutical formulation
formulation
pharmaceutical
Prior art date
Application number
DK136492A
Other languages
Danish (da)
Inventor
Hans Holmegaard Soerensen
Lars Skriver
Annie Rassing Hoelgaard
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Priority to DK136492A priority Critical patent/DK136492D0/en
Publication of DK136492D0 publication Critical patent/DK136492D0/en
Priority to DK93902089T priority patent/DK0618807T3/en
Priority to CZ941507A priority patent/CZ283361B6/en
Priority to EP93902089A priority patent/EP0618807B1/en
Priority to JP5511361A priority patent/JP2950617B2/en
Priority to AU33446/93A priority patent/AU667503B2/en
Priority to PT93902089T priority patent/PT618807E/en
Priority to EP01128974A priority patent/EP1197222B1/en
Priority to HU9401832A priority patent/HUT69402A/en
Priority to PCT/DK1992/000379 priority patent/WO1993012812A1/en
Priority to DE69233704T priority patent/DE69233704T2/en
Priority to AT01128974T priority patent/ATE368472T1/en
Priority to RU94045932A priority patent/RU2122426C1/en
Priority to CA002125855A priority patent/CA2125855C/en
Priority to KR1019940702139A priority patent/KR100266502B1/en
Priority to SK754-94A priority patent/SK279641B6/en
Priority to ES01128974T priority patent/ES2291264T3/en
Priority to UA94005308A priority patent/UA41502C2/en
Priority to AT93902089T priority patent/ATE227583T1/en
Priority to ES93902089T priority patent/ES2185625T3/en
Priority to DE69232847T priority patent/DE69232847T2/en
Priority to NZ246556A priority patent/NZ246556A/en
Priority to DE10399015C priority patent/DE10399015I1/en
Priority to RO94-01056A priority patent/RO111990B1/en
Priority to MX9207374A priority patent/MX9207374A/en
Priority to IL104152A priority patent/IL104152A/en
Priority to CN93121067A priority patent/CN1056537C/en
Priority to BG98806A priority patent/BG63075B1/en
Priority to FI942906A priority patent/FI115116B/en
Priority to NO942300A priority patent/NO942300L/en
Priority to US08/458,386 priority patent/US5849704A/en
Priority to US08/458,385 priority patent/US5849700A/en
Priority to US09/121,386 priority patent/US6022858A/en
Priority to JP11026405A priority patent/JPH11315031A/en
Priority to NL300126C priority patent/NL300126I1/en

Links

DK136492A 1991-12-20 1992-11-10 A PHARMACEUTICAL FORMULATION DK136492D0 (en)

Priority Applications (35)

Application Number Priority Date Filing Date Title
DK136492A DK136492D0 (en) 1992-11-10 1992-11-10 A PHARMACEUTICAL FORMULATION
RO94-01056A RO111990B1 (en) 1991-12-20 1992-12-16 Pharmaceutical preparations containing a raising hormone or one of its derivate and preparation process therefor
ES01128974T ES2291264T3 (en) 1991-12-20 1992-12-16 STABILIZED PHARMACEUTICAL FORMULATION UNDERSTANDING A GROWTH AND HISTIDINE HORMONE.
AT93902089T ATE227583T1 (en) 1991-12-20 1992-12-16 STABILIZED PHARMACEUTICAL FORMULATION CONTAINING GROWTH HORMONE AND HISTIDINE
EP93902089A EP0618807B1 (en) 1991-12-20 1992-12-16 A stabilized pharmaceutical formulation comprising growth hormone and histidine
JP5511361A JP2950617B2 (en) 1991-12-20 1992-12-16 Stabilized pharmaceutical formulation comprising growth hormone and histidine
UA94005308A UA41502C2 (en) 1991-12-20 1992-12-16 STABILIZED PHARMACEUTICAL PREPARATION CONTAINING GROWTH HORMONES AND HISTIDINS, GROWTH HORMYSTE CRYSTALS CONTAINING HISTIDINES AND THEIR METHOD
PT93902089T PT618807E (en) 1991-12-20 1992-12-16 STABILIZED PHARMACEUTICAL FORM COMPREHENDING HUMAN GROWTH HORMONE AND HYSTIDINE
EP01128974A EP1197222B1 (en) 1991-12-20 1992-12-16 A stabilized pharmaceutical formulation comprising growth hormone and histidine
CZ941507A CZ283361B6 (en) 1991-12-20 1992-12-16 PHARMACEUTICAL PREPARATION CONTAINING GROWTH HORMONE hGH OR A DERIVATIVE THEREOF STABILIZED AGAINST DEAMIDATION AND PROCESS FOR PREPARING THE CRYSTALLINE GROWTH HORMONE OR A DERIVATIVE THEREOF AND HISTIDINE OR DERIVATIVE THEREOF
PCT/DK1992/000379 WO1993012812A1 (en) 1991-12-20 1992-12-16 A stabilized pharmaceutical formulation comprising growth hormone and histidine
ES93902089T ES2185625T3 (en) 1991-12-20 1992-12-16 STABILIZED PHARMACEUTICAL FORMULATION THAT INCLUDES GROWTH AND HISTIDINE HORMONE.
AT01128974T ATE368472T1 (en) 1991-12-20 1992-12-16 STABILIZED PHARMACEUTICAL FORMULATION CONTAINING GROWTH HORMONE AND HISTIDINE
RU94045932A RU2122426C1 (en) 1991-12-20 1992-12-16 Pharmaceutical preparation containing growth hormone or growth hormone derivative and histidine or histidine derivative, a preparation that is growth hormone crystals containing histidine or histidine derivative and a method of preparing growth hormone crystals and histidine or histidine derivative
CA002125855A CA2125855C (en) 1991-12-20 1992-12-16 A stabilized pharmaceutical formulation comprising growth hormone and histidine
KR1019940702139A KR100266502B1 (en) 1991-12-20 1992-12-16 A stabilized pharmaceutical formulation comprising growth hormone and histidine.
SK754-94A SK279641B6 (en) 1991-12-20 1992-12-16 Stabilized pharmaceutical composition comprising growth hormone and histidine, crystals of said hormone containing histidine or derivatives thereof and method of their preparation
DK93902089T DK0618807T3 (en) 1991-12-20 1992-12-16 Stabilized pharmaceutical formulation comprising human growth hormone and histidine
AU33446/93A AU667503B2 (en) 1991-12-20 1992-12-16 A stabilized pharmaceutical formulation comprising growth hormone and histidine
HU9401832A HUT69402A (en) 1991-12-20 1992-12-16 Process for producing stabilized pharmaceutical formulations comprising growth hormone and histidine
DE69233704T DE69233704T2 (en) 1991-12-20 1992-12-16 Stabilized pharmaceutical formulation comprising growth hormone and histidine
DE69232847T DE69232847T2 (en) 1991-12-20 1992-12-16 STABILIZED PHARMACEUTICAL FORMULATION CONTAINING GROWTH HORMONE AND HISTIDINE
NZ246556A NZ246556A (en) 1991-12-20 1992-12-16 Pharmaceutical composition of a growth hormone and histidine
DE10399015C DE10399015I1 (en) 1991-12-20 1992-12-16 Stabilized pharmaceutical formulation containing growth hormone and histidine
MX9207374A MX9207374A (en) 1991-12-20 1992-12-17 PHARMACEUTICAL PREPARATION COMPRISING A GROWTH HORMONE OR A DERIVATIVE OF THE GROWTH HORMONE AND HISTIDINE OR A DERIVATIVE OF HISTIDINE.
IL104152A IL104152A (en) 1991-12-20 1992-12-18 Stabilized pharmaceutical preparation comprising growth hormone and histidine
CN93121067A CN1056537C (en) 1992-11-10 1993-11-10 A pharmaceutical formulation
BG98806A BG63075B1 (en) 1991-12-20 1994-05-30 Histidine application for the inhibition of growth hormone deamidation
FI942906A FI115116B (en) 1991-12-20 1994-06-17 Process for the preparation of growth hormone and histidine crystals
NO942300A NO942300L (en) 1991-12-20 1994-06-17 Stabilized pharmaceutical preparation comprising growth hormone and histidine
US08/458,386 US5849704A (en) 1991-12-20 1995-06-02 Pharmaceutical formulation
US08/458,385 US5849700A (en) 1991-12-20 1995-06-02 Pharmaceutical formulation
US09/121,386 US6022858A (en) 1991-12-20 1998-07-23 Pharmaceutical formulation of human-growth hormone pretreated with zinc salt
JP11026405A JPH11315031A (en) 1991-12-20 1999-02-03 Stabilized pharmaceutical preparation containing growth hormone and histidine
NL300126C NL300126I1 (en) 1991-12-20 2003-05-01 Stabilized pharmaceutical formulation that includes growth hormone and histidine.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK136492A DK136492D0 (en) 1992-11-10 1992-11-10 A PHARMACEUTICAL FORMULATION

Publications (1)

Publication Number Publication Date
DK136492D0 true DK136492D0 (en) 1992-11-10

Family

ID=8104046

Family Applications (1)

Application Number Title Priority Date Filing Date
DK136492A DK136492D0 (en) 1991-12-20 1992-11-10 A PHARMACEUTICAL FORMULATION

Country Status (2)

Country Link
CN (1) CN1056537C (en)
DK (1) DK136492D0 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS64438B1 (en) * 2018-10-26 2023-09-29 Novo Nordisk As Stable semaglutide compositions and uses thereof
CN111329996B (en) * 2020-03-03 2023-11-03 上海联合赛尔生物工程有限公司 Composition of recombinant human growth hormone and preparation method thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0374120A3 (en) * 1988-12-13 1991-07-31 Monsanto Company Comosition for controlled release of polypeptides

Also Published As

Publication number Publication date
CN1056537C (en) 2000-09-20
CN1096222A (en) 1994-12-14

Similar Documents

Publication Publication Date Title
FI934914A (en) PHARMACEUTICAL FORMULATION
FI921060A (en) PHARMACEUTICAL AEROSOLFORMULERINGAR
FI922958A (en) PHARMACEUTICAL SAMMANSAETTNING
FI922252A (en) PHARMACEUTICAL SAMMANSAETTNING
FI922316A (en) PHARMACEUTICAL SAMMANSAETTNING
NO942923L (en) drugs
FI930882A (en) PHARMACEUTICAL FORM
FI923581A (en) PHARMACEUTICAL COMBINATIONSFORMATION
NO931831D0 (en) PHARMACEUTICAL MIXTURES
BR9207062A (en) Tablet formulation
NO934145D0 (en) Pharmaceutical compounds
DE4294862T1 (en) Pharmaceutical composition
FI931251A (en) PHARMACEUTICAL FORM
DK0587047T3 (en) Pharmaceutical preparation on a progestagen basis
DK86492D0 (en) PHARMACEUTICAL PRODUCT
NO961589D0 (en) Pharmaceutical mixtures
DK0511991T3 (en) Pharmaceutical formulation
FI934387A0 (en) 3-SUBSTITUTES 2-OXI-INDOL-1-CARBOXIAMIDE PHARMACEUTICAL COMPOSITION
DK136492D0 (en) A PHARMACEUTICAL FORMULATION
IS3836A (en) Drug dispenser
NO920039L (en) PHARMACEUTICAL PREPARATIONS
TH13625EX (en) Asiologic glycoproteins - conjugated drugs
NO920564L (en) PHARMACEUTICAL ADENOS-CONTAINING PREPARATIONS
KR920010907U (en) Pharmaceutical sprayer
ITMI922580A1 (en) PHARMACEUTICAL COMPOSITION